Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents
The focus of this new book is for medicinal chemists on the chemical agents that have been used, or might be required in the future, and the methods of synthesis for inserting the reporter groups. Medicinal chemists need to know the critical issues involved in using such chemical agents with regard to the biological applications - for instance - what properties are needed chemically and why? The topics covered in the book are: PET, SPECT, contrast agents, radioimaging/radionuclide conjugates, receptor mapping, small animal imaging (eg. WBAR - whole body autoradiography); photoinduced labelling, as well as chapters on the physical techniques used including: NMR, mass spectrometry and Xray. A key reference for academics, postgraduates, researchers, industrialists and professionals working in or joining this field.
Biomedical Imaging: The Chemistry of Labels, Probes and Contrast Agents, The Royal Society of Chemistry, 2011.
Download citation file:
Digital access
Print format
Table of contents
-
Medical Imaging: Overview and the Importance of Contrastp1-20ByJohn C Waterton,, PhD CChem CSci FRSC(UK)John C Waterton,, PhD CChem CSci FRSC(UK)Personalised Healthcare & BiomarkersAstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG UKBiomedical Imaging InstituteUniversity of Manchester, Stopford Building, Oxford Road, Manchester, M13 9PT UKSearch for other works by this author on:
-
Chapter 2: Biomedical Imaging: Advances in Radiotracer and Radiopharmaceutical Chemistryp21-48ByRobert N HansonRobert N HansonMatthews Distinguished University ProfessorDepartment of Chemistry and Chemical Biology, Northeastern University, 360 Huntington Avenue, Boston, MA 02115-5000, USASearch for other works by this author on:
-
Chapter 3: Recent Developments in PET and SPECT Radioligands for CNS Imagingp49-143ByDavid Alagille;David AlagilleMolecular NeuroImaging, LLC/Institute of Neurological Disorders60 Temple Street, Suite 8A, New Haven, CT 95610, USASearch for other works by this author on:Ronald M. Baldwin;Ronald M. BaldwinMolecular NeuroImaging, LLC/Institute of Neurological Disorders60 Temple Street, Suite 8A, New Haven, CT 95610, USASearch for other works by this author on:Gilles D. TamagnanGilles D. TamagnanMolecular NeuroImaging, LLC/Institute of Neurological Disorders60 Temple Street, Suite 8A, New Haven, CT 95610, USASearch for other works by this author on:
-
Chapter 4: Design and Synthesis of Radiopharmaceuticals for SPECT Imagingp144-172ByDavid Hubers, R.Ph, BCNP;David Hubers, R.Ph, BCNPDepartment of RadiologyUniversity of Michigan Medical School, Ann Arbor, MI 48109, USASearch for other works by this author on:Peter J. H. Scott, Ph.DPeter J. H. Scott, Ph.DDepartment of RadiologyUniversity of Michigan Medical School, Ann Arbor, MI 48109, USASearch for other works by this author on:
-
Chapter 5.1: MRI Contrast Agents: Synthesis, Applications and Perspectivesp173-207ByPier Lucio Anelli*;Pier Lucio Anelli*Bracco Imaging SpA – Centro Ricerche BraccoVia Ribes 5, 10010 Colleretto Giacosa (TO)ItalySearch for other works by this author on:Luciano Lattuada;Luciano LattuadaBracco Imaging SpA – Centro Ricerche BraccoVia Ribes 5, 10010 Colleretto Giacosa (TO)ItalySearch for other works by this author on:Massimo VisigalliMassimo VisigalliBracco Imaging SpA – Centro Ricerche BraccoVia Ribes 5, 10010 Colleretto Giacosa (TO)ItalySearch for other works by this author on:
-
Chapter 5.2: The Future of Biomedical Imaging: Synthesis and Chemical Properties of the DTPA and DOTA Derivative Ligands and Their Complexesp208-260ByE. Brücher;E. BrücherUniversity of Debrecen, Department of Inorganic and Analytical ChemistryEgyetm tér 1, P. O. Box 21, Debrecen, 4010HungarySearch for other works by this author on:Zs. Baranyai;Zs. BaranyaiUniversity of Debrecen, Department of Inorganic and Analytical ChemistryEgyetm tér 1, P. O. Box 21, Debrecen, 4010HungarySearch for other works by this author on:Gy. TircsóGy. TircsóUniversity of Debrecen, Department of Inorganic and Analytical ChemistryEgyetm tér 1, P. O. Box 21, Debrecen, 4010HungarySearch for other works by this author on:
-
Chapter 5.3: MRI Contrast Agents Based on Metallofullerenesp261-284ByChun-Ying Shu;Chun-Ying ShuKey Laboratory of Molecular Nanostructure and NanotechnologyInstitute of Chemistry, Chinese Academy of Sciences, Beijing 100190ChinaSearch for other works by this author on:Chun-Ru WangChun-Ru WangKey Laboratory of Molecular Nanostructure and NanotechnologyInstitute of Chemistry, Chinese Academy of Sciences, Beijing 100190ChinaSearch for other works by this author on:
-
Chapter 5.4: Application of Magnetic Resonance Imaging (MRI) to Radiotherapyp285-308ByJenghwa Chang, Ph.D.;Jenghwa Chang, Ph.D.Department of Radiation OncologySearch for other works by this author on:Gabor Jozsef, Ph.D.;Gabor Jozsef, Ph.D.Department of Radiation OncologySearch for other works by this author on:Nicholas Sanfilippo, M.D.;Nicholas Sanfilippo, M.D.Department of Radiation OncologySearch for other works by this author on:Kerry Han, Ph.D.;Kerry Han, Ph.D.Department of Radiation OncologySearch for other works by this author on:Bachir Taouli, M.D.;Bachir Taouli, M.D.Radiology, NYU School of Medicine566 First Avenue, TCH 114 HC, New York, NY 10016, USASearch for other works by this author on:Ashwatha Narayana, M.D.;Ashwatha Narayana, M.D.Department of Radiation OncologySearch for other works by this author on:Keith DeWyngaert, Ph.D.Keith DeWyngaert, Ph.D.Department of Radiation OncologySearch for other works by this author on:
-
Chapter 6: Autoradiography in Pharmaceutical Discovery and Developmentp309-342ByEric G. Solon, PhD., QPS, LLCEric G. Solon, PhD., QPS, LLC110 Executive DriveSuite 7, Newark, Delaware, 19702, USASearch for other works by this author on:
-
Chapter 7.1: In vivo Fluorescence Optical and Multi-Modal Imaging in Pharmacological Research: From Chemistry to Therapy Monitoringp343-370ByRainer Kneuer;Rainer KneuerNovartis Institutes for BioMedical ResearchGlobal Imaging Group, CH-4056 BaselSwitzerlandSearch for other works by this author on:Hans-Ulrich Gremlich;Hans-Ulrich GremlichNovartis Institutes for BioMedical ResearchGlobal Imaging Group, CH-4056 BaselSwitzerlandSearch for other works by this author on:Nicolau Beckmann;Nicolau BeckmannNovartis Institutes for BioMedical ResearchGlobal Imaging Group, CH-4056 BaselSwitzerlandSearch for other works by this author on:Thomas Jetzfellner;Thomas JetzfellnerTechnical University of MunichInstitute for Biological and Medical ImagingGermanyHelmholtz Center MunichD-85764 NeuherbergGermanySearch for other works by this author on:Vasilis NtziachristosVasilis NtziachristosTechnical University of MunichInstitute for Biological and Medical ImagingGermanyHelmholtz Center MunichD-85764 NeuherbergGermanySearch for other works by this author on:
-
Chapter 7.2: Fluorescence Lifetime Imaging applied to Microviscosity Mapping and Fluorescence Modification Studies in Cellsp371-390ByKlaus Suhling;Klaus SuhlingDepartment of PhysicsKing's College London, Strand, London WC2R 2LSUKSearch for other works by this author on:Nicholas I. Cade;Nicholas I. CadeDepartment of PhysicsKing's College London, Strand, London WC2R 2LSUKSearch for other works by this author on:James A. Levitt;James A. LevittDepartment of PhysicsKing's College London, Strand, London WC2R 2LSUKSearch for other works by this author on:Marina K. Kuimova;Marina K. KuimovaDepartment of ChemistryImperial College London, Exhibition Road, London SW7 2AZUKSearch for other works by this author on:Pei-Hua Chung;Pei-Hua ChungDepartment of PhysicsKing's College London, Strand, London WC2R 2LSUKSearch for other works by this author on:Gokhan Yahioglu;Gokhan YahiogluDepartment of ChemistryImperial College London, Exhibition Road, London SW7 2AZUKPhotoBiotics Ltd21 Wilson Street, London EC2M 2TDUKSearch for other works by this author on:Gilbert Fruhwirth;Gilbert FruhwirthRandall Division of Cell and Molecular Biophysics and Division of Cancer Studies, Guy's Medical School CampusKing's College London, London SE1 1ULUKSearch for other works by this author on:Tony Ng;Tony NgRandall Division of Cell and Molecular Biophysics and Division of Cancer Studies, Guy's Medical School CampusKing's College London, London SE1 1ULUKSearch for other works by this author on:David RichardsDavid RichardsDepartment of PhysicsKing's College London, Strand, London WC2R 2LSUKSearch for other works by this author on:
-
Chapter 7.3: Design and Use of Contrast Agents for Ultrasound Imagingp391-410ByFabian Kiessling;Fabian KiesslingInstitute for Experimental Molecular ImagingRWTH-Aachen University, Medical Faculty, AachenGermanySearch for other works by this author on:Georg Schmitz;Georg SchmitzDepartment of Electrical Engineering and Information SciencesBochumGermanySearch for other works by this author on:Jessica GätjensJessica GätjensInstitute for Experimental Molecular ImagingRWTH-Aachen University, Medical Faculty, AachenGermanySearch for other works by this author on:
-
Chapter 8.1: Imaging as a CNS Biomarkerp411-440ByRichard Hargreaves;Richard HargreavesDiscovery Neuroscience ResearchMerck & Co. Inc., West Point, PA 19486United StatesSearch for other works by this author on:Lino Becerra;Lino BecerraP.A.I.N. Group, Massachusetts General HospitalMcLean Hospital, and Children's Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478United StatesSearch for other works by this author on:David BorsookDavid BorsookP.A.I.N. Group, Massachusetts General HospitalMcLean Hospital, and Children's Hospital, Harvard Medical School, 115 Mill Street, Belmont, MA 02478United StatesSearch for other works by this author on:
-
Chapter 8.2: Magnetic Resonance Imaging in Drug Developmentp441-464ByJin Xie;Jin XieLaboratory of Molecular Imaging and Nanomedicine (LOMIN)National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892USASearch for other works by this author on:Xiaoyuan Chen*Xiaoyuan Chen*Laboratory of Molecular Imaging and Nanomedicine (LOMIN)National Institute of Biomedical Imaging and Bioengineering (NIBIB), National Institutes of Health (NIH), Bethesda, MD 20892USASearch for other works by this author on:
-
Chapter 8.3: MRI in Practical Drug Discoveryp465-489ByK. K. Changani;K. K. ChanganiMRI Centre, GlaxoSmithKline Medicines Research CentreGunnels Wood Road, Stevenage Hertfordshire, SG1 2NYUKSearch for other works by this author on:M. V. Fachiri;M. V. FachiriMRI Centre, GlaxoSmithKline Medicines Research CentreGunnels Wood Road, Stevenage Hertfordshire, SG1 2NYUKSearch for other works by this author on:S. HoteeS. HoteeMRI Centre, GlaxoSmithKline Medicines Research CentreGunnels Wood Road, Stevenage Hertfordshire, SG1 2NYUKSearch for other works by this author on:
-
Chapter 8.4: Peering Into the Future of MRI Contrast Agentsp490-520ByDarren K. MacFarlandDarren K. MacFarlandLuna nanoWorks, a Division of Luna InnovationsIncorporated 521 Bridge St., Danville, VA 24541, United StatesSearch for other works by this author on:
Spotlight
Advertisement
Advertisement